Elucidating the precise pharmacological mechanism of action (MOA) of naturally taking place compounds may be hard. Despite the fact that Tarselli et al. (60) developed the initial de novo artificial pathway to conolidine and showcased this naturally developing compound efficiently suppresses responses to both chemically induced and inflammation-derived pain, https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers